Patents by Inventor George Reiss

George Reiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESULTS OF EMPACTA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TOCILIZUMAB IN HOSPITALIZED PATIENTS WITH COVID-19 PNEUMONIA
    Publication number: 20230357418
    Abstract: The application disclosed concerns a method of treating pneumonia in a patient who is not mechanically ventilated comprising administering an IL-6 antagonist (e.g. tocilizumab) to the patient in an amount effective to prevent the patient from dying or receiving mechanical ventilation. The disclosure is based on the results of the EM PACTA clinical trial.
    Type: Application
    Filed: March 19, 2021
    Publication date: November 9, 2023
    Applicant: Genentech, Inc.
    Inventors: Shalini V. MOHAN, William George REISS, Hoi Ying Linda YAU, Benjamin Howard KRAMER, Jian HAN
  • Systems and methods for classifying and screening biological materials for use for therapeutic and/or research purposes
    Publication number: 20100191735
    Abstract: Systems and methods collect and screen a biological material to facilitate its selection and use for therapeutic and/or research purposes. The systems and methods take into account both objective and semi-objective attributes manifest in a biological material, such as genetic, phenotypic, clinical, and genealogic attributes. The diverse array of the objective and semi-objective attributes enhances the level of confidence that the biological material can be best matched with a particular research or therapeutic purpose.
    Type: Application
    Filed: December 18, 2009
    Publication date: July 29, 2010
    Inventors: George Reiss, Linda Kelley